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ABSTRACT	 	Human	saliva	is	a	clear,	slightly	acidic	biological	fluid	containing	a	mixture	of	secretions	from	multiple	sali-vary	glands,	including	the	parotid,	sublingual	gland	other	minor	glands	beneath	the	oral	mucosa	as	well	as	gingival	crevice	fluid.		Salivary	diagnostics	has	evolved	into	a	sophisticated	science	and	serves	as	a	subset	of	the	larger	field	of	molecular	diagnostics,	now	recognized	as	a	central	player	in	a	wide	variety	of	biomedical	basic	and	clinical	areas.		Saliva	biomarkers	are	source	of	indicators	for	local,	systemic,	and	infectious	disor-ders.	The	saliva	based	microbial,	 immunologic,	and	molecular	biomarkers	offers	unique	opportunities	to	bypass	the	painful	invasive	procedures	such	as	biopsies	and	repeated	blood	draws	by	utilizing	oral	fluids	to	evaluate	the	condition	of	diseased	individuals.	Accurate	and	reliable	early	stage	disease	detection	is	the	ben-efit	of	salivary	biomarkers.	Salivary	biomarkers	represent	a	promising	non-invasive	approach	for	oral	can-cer	detection	also.	This	review	explains	about	the	salivary	biomarkers	and	their	diagnostic	approaches.	
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INTRODUCTION	Human	 saliva	 is	 composed	 of	 98%	 water	 and	 2%	other	 compounds,	 such	 as	 electrolytes,	 mucus,	antibacterial	 compounds	 and	 various	 enzymes.	Multiple	functions	of	saliva	include		solubilisation	of	food	 substances,	 food	 and	 bacterial	 clearance,	lubrication	 of	 soft	 tissues,	 bolus	 formation,	swallowing,	speech	and	facilitation	of	mastication,	all	of	which	 are	 related	 to	 its	 fluid	 characteristics	 and	specific	 components.	 Several	 types	of	 inflammatory	biomarkers	 associated	 with	 both	 oral	 diseases,	 as	well	 as	 systemic	 diseases	 have	 been	 detected	 in	
saliva,	 such	 as	 interleukins,	 tumour	necrosis	 factor.	An	increasing	number	of	specific	molecular	markers	for	different	diseases,	such	as	oral	cancer	and	breast	cancer,	 cardiovascular	 diseases	 and	 human	immunodeficiency	virus	(HIV)	and	periodontitis	are	being	 identified.	 Oral	 ﬂuids	may	 contain	molecular	information	 capable	 of	 communicating	 an	individual’s	current	state	of	health.[1]	
MATERIALS	AND	METHODS	
Salivary	genomics,	proteomics,	metabolomics	an	
transcriptomics	 biomarkers:	 The	 genomics,	transcriptomics	and	proteomics	of	saliva	represent	a	non-invasive,	 safe,	 and	 cheap	 source	 of	 complex	genetic	 information	 (Figure:1).	 The	 source	 of	 this	information	complexity	is	the	large	variety	of	DNAs,	RNAs	and	proteins	present	in	the	saliva.	
 
Figure 1: Relation	between	Salivary	genome,	
transcriptome,	proteome	and	metabolome	Salivary	 DNAs	 (genomics)	 represent	 the	 genetic	information	.	Salivary	mRNAs	provide	information	on	the	 transcription	 rates	 of	 host	 genes	(transcriptomics)	 and	 those	 of	 the	 oral	 microbes.	Other	 salivary	 RNAs	 may	 indicate	 RNA-virus	
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infections.	Salivary	proteins	 (proteomics)	 represent	both	genetic	information	(i.e.	the	mass-	spectrometry	reveals	amino	acid	sequences,	which	help	to	elucidate	the	 encoding	 genes)	 and	 help	 to	 understand	 the	translational	regulation	of	the	host	body	and	the	oral	microbes.	 Salivary	 metabolites	 generates	 the	information	about	the	body	diseased	condition.[3]	
Salivary	Genome	(Human	DNA)		The	value	of	total	DNA	content	in	human	whole	saliva	was	found	in	a	range	between	1.8	–	128.4	μg/mL	with	a	mean	value	of	21.6	μg/mL	.The	quality	and	yield	of	DNA	 that	 can	 be	 obtained	 from	 saliva	 is	 relatively	good	compared	with	blood	and	urine,	can	be	used	for	genotyping,	sequencing	 ,	and	can	be	stored	without	significant	degradation	.	Microarray	technology	is	the	method	used	to	detect	salivary	genome.	Salivary	DNA	is	 a	 robust	 analyte	 for	diagnostics,	but	 is	 limited	 to	reflecting	 presence	 or	 absence	 of	 specific	 genes,	alteration	to	sequences	(mutation)	and	methylation	status,	 and	 cannot	 provide	 information	 on	 up	regulation	and	down	regulation	of	gene	expression.[3]	
Salivary	Transcriptome	(Human	mRNA)		Although		rRNAs	and		tRNAs		are	rather	stable	in	the	cell,	mRNAs	are	usually	rapidly	degraded	.Because	of	these	reasons	mRNA	constitutes	a	small	proportion	of	 total	 cellular	 RNA	 comparing	 to	 the	much	more	abundant	 rRNA	 and	 tRNA	 fractions.	 Consequently,	extracellular	RNAs	belong	mostly	to	rRNA	and	tRNA	fractions,	whereas	the	proportion	of	mRNA	believed	to	be	the	smallest.	Messenger	(m)	RNA	is	the	direct	precursor	 of	 proteins	 and	 in	 general	 the	corresponding	levels	are	correlated	in	cells	and	tissue	samples.	 The	 main	 strategy	 to	 identify	 salivary	transcriptomic	 biomarkers	 is	 through	 microarray	technology.	 After	 profiling	 the	 transcriptomic	biomarkers	 by	 microarray,	 they	 are	 validated	 by	quantitative	 PCR	 (Polymerase	 chain	 reaction),	 the	gold	 standard	 for	 quantification	 of	 nucleic	 acids.	Salivary	 mRNA	 were	 localized	 inside	 salivary	exosomes	 and	 these	 nucleic	 acids	 were	 protected	against	ribonucleases	 in	saliva.	Exosomes	are	small,	right-side	out	cell-secreted	vesicles	of	about	30–100	nm,	derived	 from	fusion	of	multivesicular	bodies	 to	plasma	 membranes.	 These	 regulate	 the	 cell-cell	environment	 by	 altering	 their	 gene	 expression	allowing		to	better	understand	the	molecular	basis	of	oral	diseases.[3]	Examples:	KRAS	protein	(Kristen	rat	sarcoma	vius),	ACRV1	(Acrosomal	protein),	IL-6	and	IL-8.	
Salivary	Metabolomes		The	metabolome	is	the	complement	of	small	molecule	metabolites.	 Similar	 to	 the	 transcriptome	 and	proteome,	 the	metabolome	changes	continually	and	any	 single	 profile	 is	 a	 snapshot	 reflecting	 gene	 and	protein	 expression.	Metabolomic	 investigations	 can	generate	quantitative	data	for	metabolites	in	order	to	elucidate	metabolic	dynamics	related	to	disease	state	
and	 drug	 exposure.	 Using	 capillary	 electrophoresis,	these	can	be	identified.[3]	Examples:	Tryptophan,	Glutamic	acid,	Phenylalanine,	Glutamine	and	Aspartic	acid.	
Salivary	Proteomes	The	 total	 amount	 of	 proteins	 in	 whole	 saliva	 is	ranging	 between	 0.5	 to	 3	 mg/mL.	 This	 proteome	consists	of	roughly	1,000	distinct	protein	sequences,	from	 which	 around	 300	 sequences	 are	 of	 human	origin.	 A	 proportion	 ranging	 between	 22.8%	 to	28.7%	 of	 detected	 human	 sequences	 have	 an	unknown	 function.	 Analysis	 of	 saliva	 for	 protein	biomarker	 discovery	 has	 mainly	 been	 performed	using	two	dimensional	difference	gel	electrophoresis	coupled	 with	 MS	 (which	 can	 identify	 around	 300	proteins	 in	 a	 sample),	 and	 liquid	 chromatography		based	 techniques	 (which	 can	 identify	 more	 than	1,050	proteins	in	a	sample).	Several	different	classes	of	 salivary	protein	 biomarkers	 have	been	 reported.	Endothelin,	 a	 vasoconstrictor,	 was	 reported	 as	 a	potential	biomarker	for	OSCC	development.[3]	Examples:	 AZGP1	 (Alpha	 zinc	 glycoprotein),	Calprolectin	etc.	
Isolation	 and	 screening	 	 methods	 	 for	 salivary	
biomarkers	Salivary	biomarkers		isolation	and	screening	are	done	by	 different	 techniques.	 	 These	 include	 microarray	(DNA	 and	 RNA),	 capillary	 electrophoresis	 time	 of	flight	 mass	 spectrometry,	 Liquid	chromatography/mass	 spectrometry	 (LC/MS),	matrix-assisted	 laser	 desorption	 ionization–time	 of	flight/mass	spectrometry	(MALDI-TOF/MS).[4]	
PROCEDURE	
Saliva	collection	These	are	collected	by	using	passive	drool.	
Passive	 drool:	 Passive	 drool	 is	 used	 for	 saliva	collection	(figure:	2).	This	is	mainly	used	because	it	is	cost	 effective.	 To	 avoid	 problems	 with	 analyte	retention	 or	 the	 introduction	 of	 contaminants,	 use	only	high	quality	polypropylene	vials	 for	 collection,	such	 as	 	 2	 ml	 cryovials.	 	 The	 vials	 used	 must	 seal	tightly,	must	be	able	to	withstand	temperatures	down	to	-80ºC,	and	must	be	externally	threaded	to	allow	for	use	 of	 the	 Saliva	 Collection	Aid	 (SCA)	 to	 effectively	guide	drool	directly	into	the	cryovial.	A	volume	of	500	μL	whole	saliva	obtained	 through	 the	passive	drool	technique	 is	 sufficient	 to	 gather	 DNA	 for	 multiple	polymorphism	assays.[4]	1.	Remove	cap	from	cryovial		2.	 Remove	 SCA	 from	 packaging	 and	 place	 securely	into	cryovial.		3.	Instruct	participants	to	allow	saliva	to	pool	in	the	mouth.			
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4.	With	head	tilted	forward,	participants	should	drool	through	the	SCA	to	collect	saliva	in	the	cryovial.	5.	Repeat	until	sufficient	sample	is	collected.		Reserve	air	space	in	the	vial	to	accommodate	the	expansion	of	saliva	 during	 freezing.	 	 Collection	 of	 samples	 to	 be	analyzed	for	multiple	analytes	may	require	additional	cryovials.		6.	Replace	cap	onto	cryovial.[4]						
 
Figure 2: Passive drool	
Storage:	These	can	be	stored	at		-80degree	Celsius	for	several	years.	On	the	day	samples	are	to	be	screened,	bring	samples	to	room	temperature,	vortex,	and	then	centrifuge	at	1500	x	g	for	15	minutes.		If	the	samples	appear	 viscous,	 centrifuge	 for	 a	 greater	 amount	 of	time,	or	break	up	the	clot	with	a	pipette	tip	and	re-centrifuge.	 	 Screening	 should	 be	 performed	 using	only	clear	saliva.[4]	
Isolation	and	screening	methods	
Microarray	(DNA	and	RNA):	A	DNA	microarray	is	a	collection	 of	 microscopic	 DNA	 spots	 attached	 to	 a	solid	surface.	These	used	to	measure	the	expression	levels	of	large	numbers	of	genes	simultaneously	or	to	genotype	multiple	regions	of	a	genome.	The	principle	behind	 microarrays	 is	 hybridization	 between	 two	DNA	strands,	the	property	of	complementary	nucleic	acid	sequences	to	specifically	pair	with	each	other	by	forming	 hydrogen	 bonds	 between	 complementary	nucleotide	 base	 pairs.	 A	 high	 number	 of	complementary	base	pairs	 in	a	nucleotide	sequence	means	tighter	non-covalent	bonding	between	the	two	strands.	 After	 washing	 off	 non-specific	 bonding	sequences,	only	strongly	paired	strands	will	remain	hybridized.	 Fluorescently	 labelled	 target	 sequences	that	bind	to	a	probe	sequence	generate	a	signal	that	depends	 on	 the	 hybridization	 conditions	 (such	 as	temperature),	and	washing	after	hybridization.	Total	strength	of	the	signal,	from	a	spot	(feature),	depends	upon	 the	 amount	 of	 target	 sample	 binding	 to	 the	probes	present	on	that	spot.	Microarrays	use	relative	quantitation	 in	 which	 the	 intensity	 of	 a	 feature	 is	compared	to	the	intensity	of	the	same	feature	under	a	different	condition.	RNA	also	isolated	from	the	cell-free	 saliva	 by	 High-density	 oligonucleotide	microarray.[4]	
Liquid	Chromatography	Mass	Spectrometry	Mass	spectrometry	based	proteomics	has	become	the	tool	 of	 choice	 for	 identifying	 and	 quantifying	 the	proteome	 of	 an	 organism.	 The	 challenges	 of	 MS	 is	identify	 the	protein	 in	sample	and	quantifying	their	
level.	In	LC-MS-based	proteomics,	complex	mixtures	of	proteins	are	first	subjected	to	enzymatic	cleavage,	then	 the	 resulting	 peptide	 products	 are	 analyzed	using	a	mass	 spectrometer,	which	deals	with	 intact	proteins	 and	 is	 limited	 to	 simple	 protein	mixtures.		The	 experiment	 has	 the	 following	 key	 steps	 (a)	extraction	 of	 proteins	 from	 a	 sample,	 (b)	fractionation	 to	 remove	 contaminants	 and	 proteins	that	 are	 not	 of	 interest,	 especially	 high	 abundance	house-keeping	 proteins	 that	 are	 not	 usually	indicative	of	the	disease	being	studied,	(c)	digestion	of	 proteins	 into	 peptides,	 (d)	 post-digestion	separations	to	obtain	a	more	homogeneous	mixture	of	peptides,	and	(e)	analysis	by	MS.	This	technique	is	highly	accurate	and	sensitive.[4]	
Capillary	Electrophoresis	Mass	Spectrometry	This	 method	 is	 mainly	 used	 for	 the	 detection	 of	metabolites	in	saliva	and	quantifying	their	levels	on	different	 conditions.	This	 is	 an	 analytical	 chemistry	technique	 formed	 by	 the	 combination	 of	 the	 liquid	separation	process	of	capillary	electrophoresis	with	mass	 spectrometry.	 CE-MS	 combines	 advantages	 of		both	CE	and	MS	to	provide	high	separation	efficiency	and	molecular	mass	information	in	a	single	analysis.	It	has	high	resolving	power	and	sensitivity,	requires	minimal	volume	and	can	analyze	at	high	speed.	In	this	technique	the	metabolite	 is	 identified	by	comparing	peak	 produced	 with	 a	 standard	 graph.	 Each	metabolite	produce	different	peaks.[4]	
Matrix	 Assisted	 Laser	 Desorption	 Ionization	
(MALDI)	TOF	MS	In	mass	spectrometry	this	is	an	ionization	technique	that	uses	 a	 laser	 energy	absorbing	matrix	 to	 create	ions	 from	 large	 molecules	 with	 minimal	fragmentation.	It	has	been	applied	to	the	analysis	of	biomolecules	 (biopolymers	 such	 as	 DNA,	 proteins,	peptides)	 and	 large	 organic	 molecules	 (such	 as	polymers,	 dendrimers	 and	 other	 macromolecules),	which	tend	to	be	fragile	and	fragment	when	ionized	by	more	conventional	ionization	methods.		MALDI	methodology	is	a	three-step	process.	First,	the	sample	is	mixed	with	a	suitable	matrix	material	and	applied	 to	 a	 metal	 plate.	 Second,	 a	 pulsed	 laser	irradiates	 the	 sample,	 triggering	 ablation	 and	desorption	 of	 the	 sample	 and	 matrix	 material.		Finally,	 the	 analyte	molecules	 are	 ionized	 by	 being	protonated	 or	 deprotonated	 in	 the	 hot	 plume	 of	ablated	 gases,	 and	 can	 then	 be	 accelerated	 into	whichever	 mass	 spectrometer	 is	 used	 to	 analyse	them.	 This	 method	 is	 highly	 accurate,	 but	 need	experts	 to	 operate	 them.	 By	 these	 method	 the	salivary	 proteins	 and	metabolites	 can	 be	 identified	and	quantified	in	different	diseased	conditions.[4]	
Salivary	 biomarkers	 in	 oral	 squamous	 cell	
carcinoma	Oral	cancer	has	emerged	as	an	alarming	public	health	problem	 with	 increasing	 incidence	 and	 mortality	rates	 all	 over	 the	 world.	 The	 implementation	 of	
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newer	screening	and	early	detection	approaches	are	of	 utmost	 importance	 which	 could	 reduce	 the	morbidity	and	mortality	associated	with	this	disease.	Sensitive	biomarkers	for	oral	cancer	are	likely	to	be	most	 effective	 for	 screening,	 diagnosis,	 staging	 and	follow-up	for	this	dreaded	malignancy.	Unlike	other	deep	 cancers,	 oral	 cancer	 is	 located	 in	 oral	 cavity.	Hence,	 the	 direct	 contact	 between	 saliva	 and	 oral	cancer	 lesion	 makes	 the	 measurement	 of	 tumor	markers	 in	saliva	an	attractive	alternative	 to	serum	and	 tissue	 testing.	 The	 DNA,	 RNA	 and	 protein	molecules	derived	from	the	living	cancer	cells	can	be	conveniently	 obtained	 from	 saliva.	 Microscopic	investigations	 of	 the	 progressive	 cancer	 are	 often	conducted	 too	 late	 for	 intervention.	 It	 is	 also	impractical	 to	 use	 imaging	 techniques	 for	 cancer	screening,	 since	 they	 are	 time	 consuming	 and	expensive.	 These	 techniques	 are	 typically	 used	 for	conﬁrmation	 due	 to	 their	 insensitivity	 for	 small	lesions.	Many	biomarkers	have	been	identiﬁed	from	various	 body	ﬂuids.	 Among	which	 blood	 and	 saliva	are	 the	 most	 widely	 studied	 body	 ﬂuids	 that	 may	contain	 reliable	 biomarkers	 for	 detecting	 cancer.	Saliva	 has	 the	 advantages	 that	 it	 contains	 low	background	 of	 normal	 material	 and	 inhibitory	substances	as	well	as	fewer	complexes	than	blood.[5]	Among	all	 the	malignancies,	oral	cancer	 is	one	such	malignancy	where	 saliva	 examination	 for	 detection	can	 show	 the	 greatest	 beneﬁt	 because	 of	 its	 direct	contact	with	oral	 cancer	 lesions.	 Several	 studies	on	salivary	 biomarkers	 in	 oral	 cancer	 have	 shown	signiﬁcant	clinical	usefulness	for	oral	cancer.	
Table 1: Clinical significance of salivary biomarkers in 
OSCC 
Biomarkers	 Inference	
LDH, MMP-
9	
All the biomarkers are altered in 
oscc	
IL-8, TNF	 These are seen altered in oral can-
cer patients saliva	
Telomerase	 Increased telomerase activity seen 
oral cancer patients	
P53 autoanti-
bodies	
Presence of p53 autoantibodies in 
saliva of oral cancer patients	
Nitrogen spe-
cies	
Altered reactive nitrogen species 
seen in saliva of oral cancer patients	
IL-6,	 Seen altered in saliva of oral cancer 
patients	Several	reports	on	salivary	biomarkers	in	oral	cancer	have	 shown	 signiﬁcant	 clinical	 usefulness	 for	 oral	cancer	are	summarized	in	(Table	1).	As	pointed	out	in	the	table	 the	exon	4,	codon	63	of	 the	p53	gene	was	mutated	 in	salivary	DNA	from	ﬁve	of	eight	 (62.5%)	oral	 cancers	 patients.	 In	 addition,	 autoantibodies	against	 p53,	 the	 aberrantly	 expressed	 protein	 in	patients	with	oral	cancer	has	been	identiﬁed	in	both	saliva	 as	 well	 as	 serum..	 It	 is	 well	 established	 that	oxidative	 stress	 plays	 an	 important	 role	 in	progression	of	oral	cancer,	salivary	reactive	nitrogen	species	were	 signiﬁcantly	 higher,	 while	 all	 salivary	
antioxidants	 were	 signiﬁcantly	 lower	 in	 the	 oral	cancer	 patients	 as	 compared	 to	 the	 controls.	 This	increase	in	reactive	nitrogen	species	may	be	the	event	leading	to	the	consumption	and	reduction	of	salivary	antioxidants	 resulting	 in	 the	 oxidative	 damage	 to	DNA	 and	 proteins,	 and	 possibly	 leading	 to	progression	 of	 oral	 cancer.	 The	 increased	 salivary	levels	 of	 cell	 cycle	 regulatory	 proteins	 including	Cyclin	 D1	 and	 ki67,	 glycolytic	 enzyme	 lactate	dehydrogenase	 (LDH),	 matrix	 metalloproteinase	(MMP)-9,	 as	 well	 as	 reduction	 in	 DNA	 repair	enzyme8-oxoquanine	 DNA	 glycosylase	 (OGG1)	 and	Maspin	 (tumor	 suppressor	 protein	 in	 oral	 cancer	patients)		and	signiﬁcantly	increased	interleukin	(IL)-6	levels	in	saliva	of	oral	cancer	patients	is	identified.	The	 alterations	 in	 salivary	 IL-6	 and	 tumor	necrosis	factor	alpha	(TNF-a)	also	 identified	in	patients	with	oral	 cancer,	 	 observed	 that	 salivary	 IL-6	 and	TNF-a	levels	were	signiﬁcantly	higher	 	as	compared	to	the	healthy	 individuals.	 IL-6	 inactivates	 p53	 tumor	suppressor	gene	by	supporting	the	hypermethylation	of	its	promoter	region	which	results	in	suppression	of	apoptosis	 and	 uncontrolled	 cell	 proliferation.	 TNF-	alpha	 activates	 NFkB	 gene(Nuclear	 Factor	 kappa	 B	subunit)	 transcription	 factor	 which	 stimulates	 cell	proliferation	 and	 blocks	 apoptosis	 and	 additionally	enhances	 secretion	 of	 	 proinﬂammatory	 cytokines.	The	higher	salivary	levels	of	IL-1,	IL-6,	IL-8	and	TNF-a	in	oral	cancer	patients	as	compared	to	the	patients	with	dysplastic	oral	lesions	is	also	noted.	Considering,	the	 fact	 that	 same	 cytokines	 were	 signiﬁcantly	elevated	 in	 both	 oral	 cancer	 and	 oral	 premalignant	lesions,	it	may	have	a	diagnostic	value	as	the	marker	of	 malignant	 transformation	 of	 oral	 premalignant	lesions.	 Telomerase	 reactivation	 might	 be	 pre-	requisite	for	development	of	malignant	cells	from	the	somatic	 cells	 by	 escaping	 from	 the	 proliferative	limitations	 of	 cellular	 senescence.	 These	 	 has	 been	directed	 towards	 detecting	 the	 human	 papilloma	virus	(HPV)	in	saliva,	as	one	of	the	etiological	factor	in	 oral	 cancer.	 The	 incidence	 of	 HPV	 positivity	 in	patients	 treated	 for	 oral	 cancer	 is	 estimated	 to	 be	more	 than	 45%.	 With	 the	 advances	 in	 mass	spectrophotometry,	there	is	ongoing	development	in	salivary	 proteomics	 for	 biomarker	 identiﬁcation	 of	oral	 cancer.	From	depth	analysis	of	human	salivary	proteomics	 revealed	 several	 salivary	 proteins	 at	differential	 levels	between	oral	 cancer	patients	and	matched	 controls.	 These	 approach	 successfully	validated	ﬁve	candidate	biomarkers	including	Mac-2	binding	protein	(M2BP),	myeloid	related	protein	14	(MRP14),	 CD59,	 proﬁlin	 1	 and	 catalase	 using	immunoassays	 on	 independent	 set	 of	 oral	 cancer	patients	 and	 matched	 controls	 .	 Using	 quantitative	proteomics	 approach,	 	 also	 observed	 consistently	increased	levels	of	actin	and	myosin	in	saliva	samples	from	 individuals	 with	 malignant	 oral	 lesions	 as	compared	 to	 the	 premalignant	 lesions.	 From	 this	concluded	 that	 actin	 and	 myosin	 are	 promising	salivary	biomarkers	for	distinguishing	premalignant	and	malignant	oral	lesions.	Salivary	transferrin	is	also	
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validated	as	a	biomarker	for	detection	of	early	stage	oral	 cancer.	The	 tumor-speciﬁc	DNA	 in	 saliva	could	also	 be	 used	 as	 biomarker	 for	 oral	 cancer	 .	Methylation	array	of	salivary	DNA	was	supported	as	an	 effective	 biomarker	 for	 early	 detection	 of	 oral	cancer	.	Hypermethylation	on	the	promoter	of	DNA	in	speciﬁc	gene	such	as	p16	is	found	in	serum	as	well	as	also	in	saliva.	The	above	mentioned	are	some	of	the	slivary	biomarkers	that	are	significantly	used	in	the	early	detection	of	oral	cancers.[5]	
Role	of	salivary	biomarkers	in	other	diseases	Salivary	 biomarkers	 are	 used	 in	 early	 detection	 of	several	diseases	as	like	oral	squamous	cell	carcinoma	and	 	 various	 diseases	 like	 cardiovascular,	 renal	diseases,	 pancreatic	 cancer,	 perionditis	 etc.	 They	have	 also	 application	 in	 some	 areas	 like	 forensic	study	and	physiological	research.[6]	
Cardiovascular	Diseases		The	 C-reactive	 protein	 (CRP)	 can	 be	 monitored	 in	salivary	 samples,	 however	 CRP	 remains	 a	 non-specific	inflammatory	response	factor	that	increases	in	 many	 disease	 conditions.	 Similarly	 salivary	immunoglobulins	 levels	 are	 known	 to	 increase	 in	association	with	coronary	artery	disease.	A	group	of	salivary	biomarkers	 can	 complement	 findings	of	 an	electrocardiogram	 (ECG)	 following	 an	 acute	myocardial	 infarction.	 These	 markers	 include	 CRP,	myoglobin	 and	 myeloperoxidase,	 in	 combination	with	an	ECG,	showed	a	highly	significant	correlation	with	 myocardial	 infarct	 patients	 as	 compared	 to	healthy	controls.	Salivary	biomarkers	have	also	been	incorporated	into	POC	(Point	of	care)	devices	for	the	rapid	 assessment	 of	 cardiovascular	 disease	 (CVD)	with	 potential	 association	 with	 distinct	 disease	stages,	 demonstrating	 promising	 results	 to	 identify	CVD.	Elevated	salivary	lysozyme	levels,	a	biomarker	for	oral	infection	and	hyperglycemia,	has	also	shown	a	significant	association	with	hypertension,	an	early	stage	 of	 	 CVD.	 	 In	 spite	 of	 the	 progress	 made	 in	biomarker	 discovery,	 robust	 clinical	 studies	 are	required	to	validate	salivary	biomarkers	for	CVD	and	its	different	clinical	stages.[6]	
Renal	Diseases	Salivary	markers	are	associated	with	end	stage	renal	disease.	The	 list	of	markers	 include	cortisol,	nitrite,	uric	acid,	chloride,	pH,	amylase	and	lactoferrin.		The	colormetric	test	strips	were	used	to	monitor	salivary	nitrate	and	uric	acid	before	and	after	heamodialysis.	It	was	suggested	that	a	salivary	test	could	be	used	by	patients	to	decide	when	dialysis	is	required,	thereby	eliminating	 unnecessary	 visits	 to	 a	 dialysis	 clinic.	Salivary	 phosphate	 has	 been	 successfully	 used	 as	 a	clinical	biomarker	 for	hyperphosphatemia,	which	 is	an	 important	 contributor	 to	 cardiovascular	calcification	 in	chronic	 renal	 failure	 (CRF).	CRF	and	heamodialysis	 	 patients	 had	 significantly	 higher	salivary	 phosphate	 levels	 compared	 with	 healthy	control	 subjects.	 Evaluation	 of	 phosphate	 levels	 in	
saliva	 correlated	 positively	 with	 serum	 creatinine	and	the	glomerular	filtration	rate.	Salivary	phosphate	may	provide	a	better	marker	than	serum	phosphate	for	the	initiation	of	treatment	of	hyperphosphatemia	in	 CRF	 and	 HD.	 These	 results	 may	 also	 offer	 new	approaches	 in	 hyperphosphatemia	 therapy	 by	establishing	measures	to	bind	salivary	phosphate	in	the	oral	cavity	before	saliva	is	swallowed.[6]	
Physiological	Research		Stress	 and	 pain	 are	 often	 interrelated	 events.	Investigators	 have	 attempted	 to	 distinguish	 them	using	a	variety	of	model	systems	 that	 induce	either	stress	 or	 pain,	 and	 subjects	 are	 monitored	 for	changes	in	salivary	biomarkers.	Typical	markers	that	have	 been	 identified	 include	 salivary	 amylase,	cortisol,	 substance	 P,	 lysozyme	 and	 secretory	 IgA.	Pain	responses	in	dental	pulp	have	been	specifically	associated	 with	 neuropeptides	 including	 calcitonin	gene	related	peptide	(CGRP),	substance	P,	neurokinin	A	and	neurokinin	P.		Salivary	testosterone	levels	have	been	associated	with	 increased	aggressive	behavior	and	also	with	athletic	activities.[6]		
Diabetes	Mellitus	Because	 of	 the	 large	 diabetic	 population,	 combined	with	the	current	epidemic	of	Type	2	diabetes,	an	oral	test	 to	 monitor	 blood	 glucose	 would	 be	 highly	desirable.	Unfortunately,	while	it	is	relatively	easy	to	measure	salivary	glucose,	due	to	the	multiple	sources	of	 this	 material	 in	 the	 oral	 cavity,	 salivary	 glucose	levels	 do	 not	 correlate	 with	 blood	 glucose	 levels.	Recent	findings	demonstrated	a	proteomic	signature	in	saliva	obtained	from	Type-2	diabetics	as	compared	to	 control	 saliva,	with	 65	 proteins	 showing	 greater	than	 a	 2-fold	 change.	 Many	 of	 these	 proteins	 were	associated	 with	 metabolic	 and	 immune	 regulatory	pathways.		These	suggest	that	there	may	indeed	be	a	unique	 salivary	 biomarker	 profile	 associated	 with	diabetes.	Another	approach	to	detect	Type	1	diabetic	hyperglycemia	 involves	 measuring	 exhaled	 methyl	nitrate.	 These	 demonstrated	 a	 correlation	 between	blood	glucose	levels	and	exhaled	methyl	nitrate,	due	to	 interaction	 of	 superoxide	 dismutase	 with	 nitric	oxide	 as	 a	 byproduct	 of	 elevated	 oxidative	reactions.[6]	
Forensics	Salivary	 test	 have	 been	 used	 for	 a	 wide	 variety	 of	forensic	 studies.	 Samples	 can	 be	 obtained	 from	drinking	 glasses,	 envelopes,	 and	 other	 sources	 and	then	 used	 to	 detect	 blood	 group	 substances	 or	salivary	 genetic	 proteins	 (primarily	 proline	 rich	protein	 polymorphisms).	 Approximately	 85%	 of	individuals	 secrete	 blood-group	 antigens	 in	 their	saliva	including	A,	B,	H,	and	Lewis	antigens	that	have	been	 used	 for	 identification	 of	 individuals	 in	 both	criminal	 cases	 and	 paternity	 law	 suits.	 With	 the	widespread	use	of	DNA	testing,	samples	of	DNA	taken	from	 the	 buccal	 surface	 with	 an	 oral	 swab	 can	 be	easily	 obtained	 by	 untrained	 individuals.	 Saliva	 is	
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often	present	at	crime	scenes,	along	with	other	body	fluids,	 and	 since	DNA	 is	 relatively	 stable	 in	 the	dry	state,	 these	 samples	 can	 be	 used	 to	 place	 an	individual	at	the	scene	of	a	crime.[6]	
Pancreatic	Cancer	Pancreatic	 cancer	 is	 the	 second	 most	 frequent	gastrointestinal	malignancy.	Overall,	 it	 is	 the	 fourth	commonest	 cause	 of	 cancer	 related	 mortality,	reflecting	its	advanced	stage	of	presentation.	Salivary	biomarkers	are	highly	sensitive	 for	 the	detection	of		pancreatic	cancer.	Salivary	transcriptome	profiles	are	significantly	 different	 between	 patients	 with	pancreatic	 cancer	 and	 healthy	 controls.	 By	quantitative	PCR	technique,	the	expression	levels	of	two	up-regulated	mRNAs,	KRAS	and	ACRV1	and	three	down-regulated	 mRNAs	 TK2	 (Thymidine	 kinase),	GLTSCR2	 (Giloma	 tumor	 suppressor	 candidate	region)	 and	 CDKL3	 (Cyclin	 dependent	 kinase	 like)	were	 	 significantly	 different	 between	 pancreatic	cancer	 patients	 with	 healthy	 individuals.	 Further	studies	 find	 out	 that	 combination	 of	 four	 mRNA	biomarkers	 (KRAS,	 MBD3L2,	 ACRV1	 and	 DPM1)	could	 differentiate	 pancreatic	 cancer	 patients	 from	non	cancer	individuals.[6]	
CONCLUSION	From	this	review	we	understood	that	the	saliva	based	microbial,	 immunologic,	 and	 molecular	 biomarkers	offers	unique	opportunities	to	bypass	the	painful	in-vasive	 procedures	 such	 as	 biopsies	 and	 repeated	blood	 draws	 by	 utilizing	 oral	 fluids	 to	 evaluate	 the	condition	of	diseased	individuals.	Accurate	and	relia-ble	early	stage	disease	detection	is	the	benefit	of	sali-vary	 biomarkers.	 Salivary	 biomarkers	 represent	 a	promising	non-invasive	approach	for	oral	cancer	de-tection	also.	An	increasing	number	of	specific	molec-ular	 markers	 for	 different	 diseases,	 such	 as	 breast	cancer,	cardiovascular	diseases	and	human	immuno-deficiency	 virus	 (HIV)	 and	 periodontitis	 are	 being	identified.	 Oral	 ﬂuids	may	 contain	molecular	 infor-mation	capable	of	communicating	an	individual’s	cur-rent	state	of	health.	
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